A retrospective study to identify risk factors for somnolence and dizziness in patients treated with pregabalin

BACKGROUND: Pregabalin is a therapeutic drug for neuropathic pain that is associated with somnolence and dizziness. These adverse events are often experienced shortly after initiating pregabalin, and may lead to treatment discontinuation. The purpose of this study was to explore factors that influen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Hiroshi, Miyazaki, Masayuki, Takeuchi, Mio, Tsukuura, Hiroaki, Sugishita, Mihoko, Noda, Yukihiro, Yamada, Kiyofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728751/
https://www.ncbi.nlm.nih.gov/pubmed/26819733
http://dx.doi.org/10.1186/s40780-015-0022-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728751/
https://www.ncbi.nlm.nih.gov/pubmed/26819733
http://dx.doi.org/10.1186/s40780-015-0022-7

Ejemplares similares